<DOC>
	<DOCNO>NCT01128179</DOCNO>
	<brief_summary>To assess effect 12 week treatment lanthanum carbonate compare placebo serum intact Fibroblast Growth Factor 23 ( FGF23 ) level .</brief_summary>
	<brief_title>Effects Lanthanum Carbonate FGF-23 Subjects With Stage 3 CKD</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Subjects meet criterion list may include study : 1 . â‰¥18 year old . 2 . Male , nonpregnant , nonlactating female agree comply applicable contraceptive requirement protocol . 3 . Been care physician CKD &gt; 2 month , expect begin dialysis least 6 month . 4 . Screening serum cterminal FGF23 &gt; 50.0RU/mL . 5 . Screening estimate glomerular filtration rate ( eGFR ) 3059mL/min/1.73m2 use MDRD formula . 6 . Normal serum phosphate ( 0.8081.55mmol/L ) . 7 . Endogenous 25hydroxy Vitamin D level &gt; 20ng/mL . 8 . Adequate protein diet ( include 23 portion proteinrich food per day ) . 9 . An understanding , ability , willingness fully comply study procedure restriction . 10 . Ability provide write , sign , date ( personally ) inform consent participate study . Exclusion Criteria 1 . Vitamin D supplementation require . 2 . Compounds contain calcium , phosphate , aluminium magnesium require . 3 . Acute renal failure . 4 . Rapidly progress glomerulonephritis . 5 . Vegetarian diet . 6 . Known allergy iodine . 7 . Clinically significant uncontrolled concurrent illness , , opinion Investigator , would impair subject ' ability give inform consent take part complete clinical study . 8 . Cirrhosis clinically significant liver disease ( aspartate transaminase ( AST ) alanine transaminase ( ALT ) &gt; 3 time upper limit normal bilirubin &gt; 2 time upper limit normal ) . 9 . Past ( treat within last 5 year ) present GI disorder include uncontrolled peptic ulcer , Crohn 's disease ( condition integrity GI tract may compromise ) , malignancy , GI bleed within last 6 month . 10 . Lifethreatening malignancy current multiple myeloma . 11 . Known Human Immunodeficiency Virus ( HIV ) positive . 12 . History poor compliance diet medication Investigator 's opinion may interfere adherence protocol . 13 . History alcohol substance abuse within 6 month prior screen . 14 . Subjects must use another investigational medicinal product take part clinical trial within last 30 day prior enrolment . 15 . Subjects previously enrol study subsequently withdraw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>